Drugs for Neglected Diseases initiative - DNDi

The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Medecins Sans Frontieres...

Neglected diseases,drug development,leishmaniasis,human african trypanosomiasis,chagas disease,malaria,filarial diseases,paediatric hiv,open innovation,not-for-profit,r&d,medicine,research,mycetoma,hepatitis c,dengue,ntds,and neglected tropical diseases

Drugs for neglected diseases initiative - dndi operates in the Research services industry.

Drugs for neglected diseases initiative - dndi's revenue is 11m - 100m

Drugs for neglected diseases initiative - dndi has 201 - 500 employees.